Abstract Osteoclasts are specialised bone resorbing cells which form by fusion of circulating mononuclear phagocyte precursors. Bone resorption results in the release of large amounts of calcium into the extracellular fluid (ECF), but it is not certain whether changes in extracellular calcium concentration [Ca 2? ]e influence osteoclast formation and resorption. In this study, we sought to determine the effect of [Ca 2? ]e and NAADP, a potent calcium mobilising messenger that induces calcium uptake, on human osteoclast formation and resorption. CD14? human monocytes were cultured with M-CSF and RANKL in the presence of different concentrations of calcium and NAADP and the effect on osteoclast formation and resorption evaluated. We found that the number of TRAP? multinucleated cells and the extent of lacunar resorption were reduced when there was an increase in extracellular calcium and NAADP. This was associated with a decrease in RANK mRNA expression by CD14? cells. At high concentrations (20 mM 
Introduction
Osteoclasts are multinucleated cells that are specialised to carry out lacunar bone resorption [1] . Osteoclasts are formed by fusion of marrow-derived mononuclear phagocyte precursors which circulate in the monocyte fraction [2] . Osteoclast formation occurs in the presence of receptor activator for nuclear factor jB ligand (RANKL) and macrophage-colony stimulating factor (M-CSF) [3] . Osteoclasts are unique among cells in being exposed to and having to function in a microenvironment in which there is a very high calcium concentration. Dissolution of the mineral phase of bone is accomplished by a specialised area of the osteoclast membrane, the ruffled border, which is surrounded by a tight sealing zone. A large amount of calcium within the resorption lacuna is endocytosed along the osteoclast ruffled border and then transcytosed to the baso-lateral membrane area away from the bone surface from where it is released in a constant steady-state manner [4] . Intracellular organelles which act as calcium stores include the endoplasmic reticulum, Golgi apparatus and acidic lysosome-related organelles [5, 6] . Macrophages and osteoclasts are very lysosome-rich cells and nicotinic acid adenine dinucleotide phosphate (NAADP) is a universal messenger that induces calcium release from intracellular acidic lysosome-like stores, as well as calcium influx in some cases [7, 8] . An NAADP-mediated signalling pathway has been reported in many mammalian cell types, but it has not been established whether NAADP plays a role in osteoclast formation and resorption.
The calcium concentration at the resorption site may be as high as 20 mM and it is not clear what effect this extremely high level of calcium has on osteoclast formation and resorption [9] . In mouse marrow cell and osteoblast co-cultures, increased extracellular fluid calcium has been shown to stimulate osteoclast differentiation [10, 11] ; in contrast, in hematopoietic blast cell culture, high extracellular calcium has been shown to inhibit osteoclast formation and activity [12] 
Materials and Methods
Effect of Extracellular Calcium and NAADP on Human Osteoclast Formation CD14? monocytes were isolated from human buffy coat blood as previously described [13] . Cell was sorted into a CD14? cell fraction from peripheral blood mononuclear cells using an AutoMACS cell separator (Miltenyl Biotech, Surrey, UK). After incubating cells with MACS CD14 Micro Beads, the suspension was passed through the magnetic cell separator (MACS). CD14? cells were added (1 9 10 5 cell/well) to 96-well tissue culture plates containing glass coverslips and dentine slices, a-MEM culture medium (containing 1.8 mM calcium) (Lonza, Wokingham, UK) supplemented with 10 % heat-inactivated FCS, 2 mmol glutamine (Lonza), 100 iu/ml penicillin and 100 lg/ml streptomycin (Invitrogen, Paisley, UK). After 2 h incubation in a humidified incubator at 37°C and 5 % carbon dioxide, dentine slices and coverslips were transferred to 16 mm tissue culture wells containing 1 ml of medium supplemented with M-CSF (25 ng/ml) and soluble RANKL (50 ng/ml), both obtained from R&D (Abingdon, UK). All cultures were incubated for 12-14 days during which time the culture medium was replenished every 3-4 days. Negative control cultures consisted of CD14? cells incubated as above in the absence of one or both of the above factors.
To determine the effect of calcium and NAADP on osteoclast formation, CD14? monocytes were cultured in medium containing calcium (1.8-20 mM) or NAADP (0-500 lM) for 12-14 days. Evidence of the extent of osteoclast differentiation was assessed as previously described [14] by histochemical analysis of the expression of the osteoclast-associated enzyme tartrate-resistant acid phosphatase (TRAP).
In addition, functional evidence of osteoclast formation was provided by demonstration of lacunar resorption pit formation on dentine slices as previously described [13] . The extent of lacunar resorption was measured by determining surface area resorption by image analysis.
Effect of Extracellular Calcium on Osteoclast Resorption Activity
Functional mature human osteoclasts were formed from peripheral blood by culturing CD14? monocytes on hydrophobic dishes (Corning, UK) with M-CSF (25 ng/ml) and RANKL (50 ng/ml) for 19 days until osteoclasts were fully differentiated as previously described [13] . The hydrophobic surface prevents mononuclear osteoclast precursors and mature osteoclasts attaching to the dish surface; this allows collection of differentiated mature osteoclasts without causing damage to the osteoclast plasma membrane. Osteoclasts formed in this way were then seeded onto coverslips or dentine slices and cultured in medium containing calcium (1.8-20 mM) for 1,3 or 5 days. The number of TRAP? cells was counted using ImageJ. The effect of calcium on the resorbing activity of osteoclasts cultured on dentine slices was analysed using a lacunar resorption assay as described above.
Effects of Extracellular Calcium on RANK mRNA Expression in CD14? PBMC CD14? peripheral blood monocytes were isolated from fresh blood from three healthy human donors as described above. 1.5 9 10 5 cells/well were added to a 48-well plate in media containing varying concentrations of calcium (1.8-20 mM). After 1 h, 25 ng/ml M-CSF was added and cells were cultured for 24 h. RNA was extracted using the Direct-zol kit (Zymo Research) according to the manufacturer's instructions including on-column DNA digest, quantified using a Nanodrop 1000 and up to 2 lg reverse transcribed. qPCR was performed using 5 ll Fast SYBR Green Master Mix2 ll of cDNA diluted 1:10 and primers at a concentration of 225nM in a final volume of 10 ll. qPCR was performed on a Viia7 system (Applied Biosciences) using fast conditions (one cycle of 95°C for 20 s, followed by 40 cycles of 95°C for 1 s and 60°C for 20 s) with three replicates of each condition. Relative expression of RANK was calculated using the DDCT method using beta-actin (ACTB), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and beta-2-microglobulin (B2M) as reference genes and normalised to the sample cultured in media with 1.8 mM Ca 2? and M-CSF. The following primers were used: RANK forward 5
Statistical Analysis
Statistical analysis was performed in GraphPad Prism version 5. Different treatment groups were compared with each other using a one-way ANOVA, not assuming a Gaussian distribution, with post hoc testing using Dunn's multiple comparison test. Significance was designated as * p \ 0.05, ** p \ 0.01, *** p \ 0.001.
Results

Effect of Calcium and NAADP on Osteoclast Formation
A dose response inhibitory effect on osteoclast formation in increasing concentrations of extracellular calcium was noted in cultures of human monocytes incubated with RANKL and M-CSF. The number of TRAP? multinucleated cells and the extent of lacunar resorption showed a step-wise decrease over the concentration range 1.8-20 mM Ca 2? (Figs. 1a, 2 ). Cultures of monocytes incubated on dentine slices with RANKL and M-CSF showed a similar decrease in lacunar resorption reflecting the reduction in the number of multinucleated cells (Fig. 1b) . Minimal or no osteoclast formation was seen in RANKL and M-CSF-treated monocyte cultures incubated at 20 mM Ca 2? calcium. The number of osteoclasts formed in monocyte cultures incubated at 5 mM Ca 2? was not significantly different to that seen in control cultures. There was an observable decrease in the number of TRAP? mononuclear cells, but no change in morphology over the 14-day period of culture at high levels of extracellular calcium.
The addition of NAADP also had an effect on the number of osteoclasts and the extent of resorption seen in monocyte cultures incubated with RANKL and M-CSF (Fig. 3a, b) . In general, at high NAADP concentration (100 and 500 lM), a decrease in osteoclast formation and resorption was noted. Osteoclast numbers and resorption were not significantly different to controls at 10 mM, but were decreased at higher concentrations (100 and 500 lM).
There was an observable decrease in the number of TRAP? mononuclear cells, but no change in morphology over the 14-day period of culture at high levels of extracellular NAADP.
The Effect of Calcium on Osteoclast Resorption Activity
The number of TRAP? multinucleated cells remains unchanged after mature osteoclasts (formed from CD14? cells under normocalcemic conditions) were reseeded and cultured in media containing high concentrations of calcium (Fig. 4a) . The ability of mature osteoclasts to resorb bone, as measured by the formation of lacunar resorption pits, was not significantly altered at high calcium concentrations (Fig. 4b) Calcium is the fifth most abundant inorganic element in the body. 99 % of body calcium are in bone and teeth in the form of hydroxyapatite [15] . Approximately 1 % of total body calcium is intracellular with 0.1 % extracellular. A small component of bone calcium is rapidly exchangeable with the extracellular compartment and in this way contributes to the rapidly responsive regulation of extracellular calcium. A reduction in [Ca 2? ]e stimulates the release of PTH which acts to enhance osteoclast formation and resorption, resulting in the liberation of calcium and phosphate from the skeleton. The osteoclast is unique in mobilising massive quantities of calcium from bone. This results in high levels of calcium at the site where osteoclasts are formed by fusion of mononuclear precursors. In a b ]e with a decreasing numbers as [Ca 2? ]e is increased to 20 mM. Scale bar represents 100 lm this study, we found that when the [Ca 2? ]e concentration was increased, there was a decrease in human osteoclast formation from CD14? monocytes which showed a decrease in RANK expression. The Ca 2? -NFATc1 signalling pathway is essential for osteoclast differentiation [16, 17] and there is evidence that osteoclasts express calciumsensing ryanodine receptor (RyR). NFATc1 is activated by Ca 2? signalling through adapters harbouring immunoreceptor tyrosine-based activation motifs. It is thought that calcium oscillations that occur during osteoclastogenesis induce NFATc1 through an autoamplification mechanism. In mice, RANKL induces oscillations in the intracellular concentration of calcium which plays a switch-on role in NFATc1 expression and osteoclast differentiation. These oscillations are essential for the terminal differentiation of mononuclear phagocytes into osteoclasts. NFAT transcription factors are regulated by calcineurin, a serine/ threonine phosphatise, which is activated by intracellular calcium [16, 17] . Inhibitors of calcineurin, as well as calcium chelators, inhibit RANKL-induced osteoclast formation through inhibition of NFATc1. The precise mechanism whereby NFATc1 controls osteoclast formation is uncertain, but it is known that a number of osteoclast-specific genes, including calcitonin receptor, cathepsin K ,and a3 integrin, are regulated by NFATc1 [17] . Most studies on the effect of extracellular calcium on osteoclast formation have been carried out in mice. Some of these studies have shown that high extracellular calcium stimulates osteoclast-like cell formation and bone resorbing activity [10, 11] . Other studies looking at the effect of factors that influence osteoclast differentiation, such as zinc, gallium and calcium release-activated channels have shown inhibition of osteoclast differentiation in response to an increase in [Ca 2 ? ]e and have noted that this is associated with changes in the Ca 2? -calcineurin-NFATc1 signalling pathway [18] [19] [20] [21] [22] . Our findings indicate that human osteoclastogenesis is also sensitive to [Ca 2? ]e from CD14? monocyte/macrophage osteoclast precursors and that this may in part be modulated through changes in RANK expression by human mononuclear phagocyte osteoclast precursors.
In contrast to the effect of extracellular calcium on osteoclast formation, we found lacunar resorption by mature osteoclasts, derived under normocalcaemic conditions, was little altered by the presence of high [Ca 2? ]e. Changes in [Ca 2? ]e have previously been shown to influence the behaviour of osteoclastic giant cells in giant cell tumour of bone [23] . The osteoclast acidifies the extracellular compartment by secreting protons across the ruffled border membrane via a vacuolar-like H ?/-ATPase proton pump [1, 23] . The protons are provided by the enzyme carbonic anhydrase type II, which generates H? and HCO 3-ions from CO 2 . Intracellular pH is maintained by a chloride/bicarbonate exchanger on the anti-resorptive surface and electroneutrality is maintained by a chloride channel (CLC-7) located in the ruffled border membrane, which transports Cl -into the resorption lacuna [1] . Ambient calcium concentration levels may be as high as 8-20 mM following bone mineral dissolution by osteoclast activity. Such extracellular calcium concentration changes alter bone resorbing activity of isolated rat osteoclasts and this is accompanied by rapid and sustained changes in cytosolic calcium concentration and cell retraction with inhibition of enzyme release and bone resorption. High calcium at sites of active osteoclast resorption have been shown in animal models to cause cell retraction, disappearance of the sealing zone and apoptosis, all of which would result in a decrease in bone resorption [9] . These findings suggest the existence of long-and short-term feedback mechanisms on osteoclast activity, controlled by an increase in [Ca 2? ]e. However, our findings indicate that osteoclast resorption activity by mature osteoclasts was not altered by extracellular concentrations of calcium. Functional compartments for calcium mobilisation in osteoclasts may enable the osteoclast to operate whilst in contact with a high [Ca 2? ]e environment, but the precise molecular pathways and intracellular mechanisms used by osteoclasts to deal with a high calcium load have not been determined. ]e environment; however, the precise molecular pathways and intracellular mechanisms used by osteoclasts to deal with a high calcium load have not been determined.
Macrophages and osteoclasts are both lysosome-rich cells. NAADP is a universal messenger that induces calcium release from intracellular stores, as well as calcium influx in some cases [7, 8] . The NAADP-mediated signalling pathway has been reported in many mammalian cell types. NAADP is the most potent calcium mobilising messenger that has been discovered so far, with a low nanomolar concentration for activating its receptor. NA-ADP has been demonstrated to induce calcium release from acidic lysosome-like stores via a pathway distinct from other calcium-releasing messengers, inositol triphosphate (IP3), and cyclic ADP Ribose (cADPR). The production of NAADP is catalysed by ADP-ribosyl cyclases via a base-exchange reaction that converts the nicotinamide group of NADP to the nicotinic acid at acidic pH (pH 4.5). CD38, a homolog of ADP-ribosyl cyclase, which catalyses the synthesis of NAADP, is present on the plasma membrane of both monocytes and osteoclasts [24] . Moreover, the low pH in the hemivacuole provides an acidic environment that favours NAADP synthesis. It has been shown that two pore channels (TPCs), a family of cation channels, are located on lysosome-like acidic stores and that NAADP is likely to induce calcium release through TPC2 [25] . Our findings indicate that changes in the concentration of NAADP influence osteoclast formation from CD14? mononuclear phagocytes, suggesting that it may also play a role in modulating calcium transport in these cells. It has recently been shown that TPC2 is expressed in osteoclast precursor cells and that breaking down TPC2 in these cells suppresses RANKL-induced key events including TRAP expression [26] . Moreover, knockdowns of TPC2 reduce the levels of RANKL-induced dynamic waving of calcium in osteoclast precursors. TPC2 suppression also inhibited osteoclast pit formation in culture. It is postulated that the target of TPC2 is nuclear localisation of NFATC1.
To complete bulk calcium transport, the high calcium solution at the osteoclast attachment site must be moved to and diluted in the extracellular space. Some calcium may be released when the osteoclast detaches, but the bulk of the transport of calcium occurs through the osteoclast by vacuolar transcytosis. There is good evidence for the presence of calcium-binding proteins and an epithelial calcium channel TRPV5 that supports a calcium transport mechanism. The osteoclast has several other transport proteins including a Ca 2? -ATPase, which is expressed highly in osteoclasts. The massive calcium movement that occurs in bone resorption undoubtedly requires that the osteoclast has a mechanism for protecting cytoplasmic and organelle calcium content even if the bulk transport is vesicular. Osteoclasts are very lysosome-rich cells and are thus likely to contain NAADP receptors. Although NAADP cannot cross the plasma membrane because it is highly negatively charged, it has been shown that NAADP can be taken up by some cell types [27] . It is thus possible that any NAADP produced in the hemivacuole could be taken up into osteoclasts and play a role in calcium signalling by influencing osteoclast differentiation and function.
